Board of Directors

Mr. Grantham co-founded GMO in 1977 and is a member of GMO’s Asset Allocation team, serving as the firm’s long-term investment strategist. He is the Chairman of the GMO Board of Directors, a partner of the firm, and has also served on the investment boards of several non-profit organizations. Prior to GMO’s founding, Mr. Grantham was co-founder of Batterymarch Financial Management in 1969 where he recommended commercial indexing in 1971, one of several claims to being first. He began his investment career as an economist with Royal Dutch Shell. Mr. Grantham earned his undergraduate degree from the University of Sheffield (U.K.) and an MBA from Harvard Business School. He is a member of the Academy of Arts and Sciences, holds a CBE from the UK and is a recipient of the Carnegie Medal for Philanthropy.

Mr. Harris is a member of the GMO Board of Directors. He has a diverse and extensive career in the financial services industry. Currently, he serves as a Senior Advisor, Director, and Chairman at Oddo BHF UK Ltd., a role he has held since November 2022. Oddo BHF is a Continental European business involved in asset management, wealth management, equity broking, and corporate finance activities. In addition to his role at Oddo BHF, Mr. Harris is an Independent Supervisory Board Member at HarbourVest Partners, a position he has held since September 2021. He also served as a Board Member at FNZ Group from 2024 to February 2025. His experience extends to academia as well, having been a Member of the Board of Trustees at Colby-Sawyer College from July 2021 to October 2024. Mr. Harris’s previous roles include significant leadership positions at BNY Mellon Investment Management, where he was the Chief Executive Officer from February 2016 to October 2020 and President from April 2011 to February 2016. Mr. Harris received a Master of Public Administration from the University at Albany.

Mr. Hayward is the Chief Executive Officer of GMO, a member of the GMO Board of Directors and a partner of the firm. Prior to joining GMO in 2017, he served as the Chief Executive Officer and Chairman of Quantitative Management Associates LLC (QMA) for 11 years. Previously, he was the Head of Client Relations at QMA and Jennison Associates (both affiliates of Prudential Financial, Inc.). Prior to joining QMA and Jennison Associates in 2003, Mr. Hayward served as Managing Director, Head of Institutional Client Services and Marketing at J.P. Morgan Asset Management. Prior to that, he was a Vice President and served in a variety of roles in the investment bank, private bank, and corporate divisions at J.P. Morgan & Co. Mr. Hayward earned his bachelor's degree in Political Science from Boston College.

Broker check

Mr. Hene is a portfolio manager for GMO’s Quality Strategies and a member of the Focused Equity team. He is also a member of the GMO Board of Directors and a partner of the firm. Previously at GMO, he was engaged in portfolio management within the Global Equity team. Mr. Hene joined GMO full-time in 1995. He has an MSc in Biochemistry from the University of Oxford and is a CFA charterholder.

Mr. Inker is Co-Head of GMO’s Asset Allocation team and a portfolio manager for the team’s products. Mr. Inker is a member of the GMO Board of Directors and a partner of the firm. He joined GMO in 1992 following the completion of his bachelor's degree in Economics from Yale University. In his years at GMO, Mr. Inker has served as an analyst for the Quantitative Equity and Asset Allocation teams, as a portfolio manager of several equity and asset allocation portfolios, as Co-Head of International Quantitative Equities, and as CIO of Quantitative Developed Equities. He is a CFA charterholder.

Ms. McGetrick is a member of the GMO Board of Directors. Previously, Ms. McGetrick was a founding partner of Liberty Square Asset Management and portfolio manager. In her previous employment with GMO from 1984 to 1996, she was a portfolio manager on the International Active Equity team and was also partner of the firm from 1988 through 1997. Ms. McGetrick began her investment career in non-US equities in 1982 as an analyst for The Commonfund for International Investments. She currently serves on the Board of Save the Children, where she is also chair of the Investment Committee, and formerly served on the Investment Committees of Partners Healthcare System, Providence College, and The Wheeler School. Ms. McGetrick graduated from Providence College with a bachelor's degree in Psychology and Business Management and a MS in Finance from Fairfield University.

Ms. Muller is a member of the GMO Board of Directors. She is an experienced CEO and financial services executive with a diverse global background in asset management, credit rating, investment banking, and law in addition to significant Board and working experience with investment boutiques. She spent most of her career outside of the U.S., including 15 years in Asia and 10 years in Europe, in addition to 8 years in the U.S. Ms. Muller currently serves as a Non-Executive Director on the Board of Directors at Burford Capital Limited and on Advisory Boards for Forward Risk and Intelligence and the Business Law Scholars Program at Georgetown University Law Center. Previously, she was a member of the Operating Committee for Principal Global Investors, including as CEO of Asia and Global Head of Institutional Business. Prior to that, she was Head of Asia-Pacific for Fitch Ratings and Managing Director at UBS in both France and Singapore specializing in capital markets and institutional asset management sales. Ms. Muller began her career at Shearman & Sterling, where she was a European partner and worked as a corporate lawyer in both New York and Paris. She has a B.S. from Georgetown University School of Foreign Service, a Masters in European Union Studies from the College of Europe in Belgium, and a J.D. from Georgetown Law Center.

Dr. Nitzberg is a member of the GMO Board. He has more than twenty-five years' experience founding, managing, and advising technology-oriented companies. Dr. Nitzberg is currently Executive Director of the Center for Human-Compatible Artificial Intelligence and Head of Strategic Outreach for Berkeley Artificial Intelligence Research at the University of California, Berkeley. He also currently serves in advisory, board, and other executive roles for DM Group, Grabango, Akvo Foundation USA, Spoondrift Technologies, and Cambrian Group. Previously, he was Director of Computer Vision Products at A9, an Amazon subsidiary focused on search engine and search advertising technology, following Amazon’s acquisition of The Blindsight Corporation, where Dr. Nitzberg was the founding CEO. Prior to that, he co-founded Smartleaf, a provider of automated portfolio rebalancing and tax optimization solutions for wealth managers, RIAs, broker-dealers, and banks. He also co-founded RapidCare, Inc., and served in leadership roles at Viaweb. Dr. Nitzberg earned his B.A. in Mathematics and Music Composition from the University of Oregon and his Ph.D. in Computer Science from Harvard University.